Nicholas B Norgard (Nicholas Norgard)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Postgraduate medicine

Cardiovascular therapeutics

Clinical pharmacokinetics

University of Missouri Kansas City

University of Nebraska Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Missouri Kansas City Sep 01 2016

United States

Associate Teaching Professor :: Medicine

SUNY College at Buffalo Aug 01 2008 - Sep 01 2016

United States

Clinical Assistant Professor :: Pharmacy

Education History

University of Nebraska Medical Center Sep 01 2000 - Jun 01 2004

United States

PHD

Publications

Angel López-Candales, Scott Monte, Khalid Sawalha, Nicholas B Norgard
Time to revisit the true role of metformin in type 2 diabetes mellitus. Postgraduate medicine (2023)
Angel López-Candales, Talal Asif, Khalid Sawalha, Nicholas B Norgard
Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic Dysfunction. Cardiovascular therapeutics 2023 (2023)
Angel López-Candales, Khalid Sawalha, Betty M Drees, Nicholas B Norgard
In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patients. Postgraduate medicine (2023)
Angel López-Candales, Khalid Sawalha, Betty M Drees, Nicholas B Norgard
In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patients. Postgraduate medicine (2023)
Angel López-Candales, Nicholas B Norgard
Will the new pharmaceutical lipid-aspirin complex formulation restore the once lost trust of aspirin on cardiovascular protection? Postgraduate medicine 134 (6) (2022)
Satya Preetham Gunta, Roopesh Sai Jakulla, Aamer Ubaid, Kareem Mohamed, Abid Bhat, Angel López-Candales, Nicholas B Norgard
Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022. Cardiovascular therapeutics 2022 (2022)
Nicholas B Norgard, Angel López-Candales
The rise of SGLT2 inhibitors: the time is now for cardiovascular specialists to lead the charge. Postgraduate medicine (2021)
Nicholas B Norgard
Obesity and Altered Aspirin Pharmacology. Clinical pharmacokinetics 57 (6) (2019)

Nicholas B Norgard.css-eqlu8i{font-size:small;padding-left:4px;} (Nicholas Norgard)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas B Norgard (Nicholas Norgard)